Glucosamine Side Effects: What the Safety Data Actually Shows
Glucosamine is one of the best-tolerated supplements studied. In the literature, adverse effects occur in fewer than 5 percent of users (European Association for the Study of the Liver, 2013). But two risks are real and documented, and both are specific: a warfarin interaction with published case numbers, and a shellfish-allergy question that the clinical evidence answers better than most labels do. This page covers the common complaints, the warfarin case data, the allergy evidence and the rare flags, with sources for every claim.
Written and fact-checked by RecallPath Editorial Team. Last updated: . About our editorial process.
- Overall safety: adverse effects in fewer than 5 percent of users in published data (EASL, 2013).
- The warfarin interaction: documented case reports with INR jumps from 2.3 to 3.9 and up to 4.7 (Knudsen et al., 2008). FDA MedWatch logged 20 reports; WHO database logged 21.
- Shellfish allergy: 15 shellfish-allergic volunteers tolerated 1,500 mg shrimp-derived glucosamine in a controlled challenge (Villacis et al., 2006). Major clinics still advise caution.
- Rare flags: liver enzyme elevations in people with chronic liver disease, possible asthma worsening, possible eye-pressure increase.
Common side effects
The common complaints are gastrointestinal and mild. The Mayo Clinic lists nausea, heartburn, diarrhea and constipation, along with drowsiness, headache and skin reactions. The UK’s NICE formulary (BNF) adds fatigue and general GI discomfort to the same list. In controlled trials, these rates sit close to placebo, which is why glucosamine’s overall adverse-effect rate is estimated below 5 percent.
Adverse-effect rate in published glucosamine data (EASL, 2013)
Spontaneous INR-elevation reports in the WHO database; 17 resolved after stopping
Altered-coagulation reports to FDA MedWatch (2000-2008)
For most healthy adults, that is the whole story: mild stomach complaints that often fade with food, and rates similar to taking nothing at all. The sections below cover the cases where the answer changes.
The warfarin interaction: documented case numbers
This is the one serious, well-documented interaction, and it deserves specifics rather than a vague warning. Knudsen et al. (Annals of Pharmacotherapy, 2008, PMID 18363538) reported a 71-year-old man on stable warfarin therapy for five years, INR holding at 2.3. Three weeks after he doubled his glucosamine-chondroitin dose to 1,500 mg and 1,200 mg twice daily, his INR had climbed to 3.9. Sixteen days after the dose was cut, it hit 4.7. The supplements were stopped, and INR returned to 2.6 sixteen days later.
The reporting databases show the pattern repeating. Between 2000 and 2008, FDA MedWatch received 20 reports of altered coagulation linked to glucosamine. The WHO adverse-event database holds 21 spontaneous reports of increased INR; 17 of them resolved when the supplement was discontinued.
UK clinical guidance is blunt: avoid the combination, or if used at all, take it consistently and increase INR monitoring when starting or stopping (Sheffield clinical guidance, cited in Knudsen et al., 2008). If you take warfarin, or any anticoagulant, this is a decision for your doctor with blood monitoring, not a supplement-label fine print.
Shellfish allergy: the evidence vs the label warning
What the controlled data actually shows
Most glucosamine is extracted from shrimp, crab and lobster shells. Shellfish allergy, however, is a reaction to proteins concentrated in the flesh, chiefly tropomyosin, not to the shell itself (Verma et al., 2024). That is why the clinical data is more reassuring than the marketing warnings: Villacis et al. (2006, PMID 17083356) gave 1,500 mg of shrimp-derived glucosamine to 15 volunteers with confirmed shrimp allergy in a double-blind, placebo-controlled challenge. All 15 tolerated it. No immediate or delayed reactions occurred.
Major clinics are more conservative. The Mayo Clinic still advises people with shellfish allergy to avoid glucosamine or choose caution. Both positions can be true: the measured risk looks low, and the cheapest way to eliminate it entirely is a fermentation-derived product, which contains no shellfish material at all.
Rare flags: liver, asthma, eyes, blood sugar
Liver enzyme elevations
A prospective series from the Spanish hepatotoxicity registry recorded transaminase elevations in people with chronic liver disease who used glucosamine-containing products; enzyme levels reverted after discontinuation (EASL, 2013). If you have chronic liver disease, treat glucosamine like any new supplement: clear it with your hepatologist first.
Asthma
The Mayo Clinic notes that glucosamine might worsen asthma. People with poorly controlled asthma should monitor symptoms when starting and stop if breathing worsens.
Eye pressure and glaucoma
The Mayo Clinic also flags a possible increase in eye pressure. If you have glaucoma or elevated intraocular pressure, mention glucosamine to your eye doctor before starting.
Blood sugar
Glucosamine is a sugar molecule, and early theoretical concern about insulin resistance was legitimate. Controlled studies have since found no meaningful glucose effect at standard doses (StatPearls, 2025). People with diabetes on medication should still monitor blood sugar when starting, since individual responses vary.
Who should skip glucosamine or check first
- Warfarin or other anticoagulant users. Documented INR elevation. Avoid unless your doctor manages it with monitoring.
- People with severe shellfish allergy who cannot confirm a fermentation-derived source.
- Chronic liver disease. Published case signal. Clear it with your specialist first.
- Uncontrolled asthma, glaucoma, diabetes on medication. Possible interactions. Start only with monitoring.
- Pregnancy and breastfeeding. Human safety data is insufficient. Skip it.
- People on chemotherapy. WebMD flags potential interactions with doxorubicin and etoposide. Oncology first, supplements second.
The bottom line
For a healthy adult, glucosamine’s side-effect profile is closer to a food than a drug: mild stomach complaints, rates near placebo, adverse events under 5 percent. The risk picture changes only in specific groups, and every one of them is avoidable with one conversation: warfarin users, shellfish-allergic buyers who skip the source check, and people with liver disease or uncontrolled asthma. Have that conversation once, and glucosamine is a low-risk supplement. Skip it, and a 2.3-to-4.7 INR swing is what the case reports look like.
Frequently Asked Questions
Is glucosamine safe to take every day?
For most healthy adults, yes. Adverse effects occur in fewer than 5 percent of users in published data, and trials running one to three years report no accumulation of risk. The exceptions are specific: warfarin users, people with chronic liver disease, uncontrolled asthma, glaucoma, and pregnancy. Those groups should not self-start.
Can glucosamine cause bleeding?
By itself, rarely. The documented problem is the combination with warfarin. A published case report shows INR rising from 2.3 to 3.9 in three weeks on a doubled dose, then to 4.7 (Knudsen et al., 2008). FDA MedWatch logged 20 altered-coagulation reports and the WHO database 21 INR reports between 2000 and 2008, most resolving after stopping.
Is glucosamine safe with a shellfish allergy?
The clinical evidence says usually yes, because the allergen lives in the flesh, not the shell. In a controlled challenge, 15 confirmed shellfish-allergic volunteers all tolerated 1,500 mg of shrimp-derived glucosamine (Villacis et al., 2006). Major clinics still advise caution. The zero-risk option is a fermentation-derived glucosamine, which contains no shellfish material.
Does glucosamine raise blood sugar?
Controlled studies have not confirmed a meaningful effect at standard doses; the early insulin-resistance theory has largely been refuted (StatPearls, 2025). People with diabetes on medication should still check blood sugar when starting, because individual monitoring is cheap and the interaction data in diabetics is thinner than in the general population.
Is glucosamine hard on the kidneys or liver?
Healthy kidneys handle glucosamine without documented strain. The liver has one published case signal: transaminase elevations in people with pre-existing chronic liver disease, reversed after stopping (EASL, 2013). If your liver is healthy, the data shows no meaningful risk. If it is not, clear it with your hepatologist first.
Does chondroitin have the same side effects?
Mostly. Chondroitin shares the mild GI profile: nausea, diarrhea, constipation. It comes from cow or shark cartilage rather than shellfish, so the shellfish question does not apply. The warfarin caution extends to the combination product, since that is what the case reports tracked. The full ingredient breakdown is in our glucosamine chondroitin guide.
What should I do if I get side effects?
For mild stomach upset, take the dose with food and give it one to two weeks. If nausea, diarrhea or headache persist past that, stop. If you are on warfarin and notice unusual bruising or nosebleeds, stop and contact your doctor the same day for an INR check. Do not taper; glucosamine needs no taper.
Sources and References
- Knudsen et al. – Potential glucosamine-warfarin interaction – Annals of Pharmacotherapy, 2008 (PMID 18363538)
- Glucosamine – Mayo Clinic
- Hepatotoxicity case series, EASL registry – PMC3752575
- Villacis et al. – Do shrimp-allergic individuals tolerate glucosamine? – J Allergy Clin Immunol, 2006 (PMID 17083356)
- Glucosamine – StatPearls, NCBI Bookshelf, 2025
- Glucosamine – NICE British National Formulary
Need help choosing?
RecallPath does not sell supplements. We publish facts for readers over 40.
Email us